Sign In
Buy DHR
$178.08
+1.97 (+1.12%)
At Close: Jun 03, 2026
Danaher Announces Transition Plan for Chief Financial Officer
06:02am, Tuesday, 22'nd Jul 2025
WASHINGTON , July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financi
Danaher Reports Second Quarter 2025 Results
06:00am, Tuesday, 22'nd Jul 2025
WASHINGTON , July 22, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended June 27, 2025. Key Second Quarter 2025 Results Net earnings we
Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?
12:31pm, Friday, 18'th Jul 2025
DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential.
Danaher (DHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
10:15am, Thursday, 17'th Jul 2025
Evaluate the expected performance of Danaher (DHR) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for
45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs
09:14am, Thursday, 17'th Jul 2025
I analyze Barron's Mid-Year 2025 Roundtable Pro Picks using the yield-based 'dogcatcher' method to identify high-yield, safer dividend stocks. AT&T, Tegna, and Pitney Bowes stand out as 'safer' divide
Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside
04:23am, Monday, 30'th Jun 2025
Danaher is positioned for a revenue rebound, led by strong bioprocessing demand and resilient recurring sales, despite short-term headwinds in Life Sciences and China. Margin outlook is stable, suppor
CVS vs. DHR: Which Stock Is the Better Value Option?
12:41pm, Friday, 27'th Jun 2025
Investors interested in stocks from the Medical Services sector have probably already heard of CVS Health (CVS) and Danaher (DHR). But which of these two stocks offers value investors a better bang fo
Danaher Appoints Martin Stumpe as Chief Technology and AI Officer
07:35am, Friday, 27'th Jun 2025
WASHINGTON , June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technol
Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences
07:30am, Friday, 27'th Jun 2025
WASHINGTON , June 27, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Bo
Why Danaher (DHR) is a Top Growth Stock for the Long-Term
10:51am, Friday, 20'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Danaher: High Capex And Low Debt Despite Trump Legislation
12:33pm, Thursday, 19'th Jun 2025
The company has achieved returns on equity above 7.8% since 2019. Additionally, it reduced its liabilities-to-assets ratio to 35.72% this quarter, indicating a low risk of bankruptcy. Danaher expects
Danaher Schedules Second Quarter 2025 Earnings Conference Call
04:30pm, Tuesday, 17'th Jun 2025
WASHINGTON , June 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2025 on Tuesday, July 22, 2025
CVS vs. DHR: Which Stock Should Value Investors Buy Now?
12:40pm, Wednesday, 11'th Jun 2025
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations
07:00am, Monday, 02'nd Jun 2025
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #AI--SCIEX announces three software ecosystem enhancements at ASMS, supporting the theme that “all science is data science now.”.
SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement
07:00am, Monday, 02'nd Jun 2025
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- #Evocep--SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement.
